Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline versus bromocriptine for premenstrual mastalgia
ACTRN12608000543381Phase 2Completed
- Sponsor
- Sisli Etfal Training and Research Hospital
- Start
- Sep 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cabergoline and bromocriptine in mastalgia and cyclical mastalgia (2 arms), sponsored by Sisli Etfal Training and Research Hospital. Primary endpoint: Breast pain visual analogue score. Started Sep 2007; status: completed.
02
Drugs
cabergolinebromocriptine
03
Conditions
mastalgiacyclical mastalgia
Beyond the preview
Go deeper on ACTRN12608000543381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000543381.